In a bid to expand its efforts in pain management, San Diego, California-based specialty pharmaceutical company Pacira Pharmaceuticals is spending up to $220 million to acquire MyoScience, a medical ...
SAN DIEGO, Dec. 18 /PRNewswire/ -- Pacira Pharmaceuticals, Inc., a leader in sustained release injectable technologies, today announced that David M. Stack has been selected as President, Chief ...
SAN DIEGO, May 13, 2025 /PRNewswire/ -- Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Pacira BioSciences, Inc. (NASDAQ: PCRX). Investors who ...
Phase II data with San Diego-based Heron Therapeutics Inc.’s pain drug HTX-011 (Zynrelef) graced the online pages of the Journal of the American Podiatric Medical Association in early January, ...
or contact Joseph E. Levi, Esq. via email at [email protected] or call (212) 363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit ...
NEW YORK CITY, NY / ACCESS Newswire / December 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Pacira BioSciences, Inc. ("Pacira" or "the ...
Pacira (PCRX) BioSciences announced the receipt of U.S. Patent No. 12,156,940 from the U.S. Patent and Trademark Office, the U.S. PTO. The ‘940 patent, entitled “Manufacturing of Bupivacaine ...
Good day, and thank you for standing by. Welcome to the Q3 2023 Pacira BioSciences Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, ...
See “Non-GAAP Financial Information” below. “Throughout the second quarter, we continued to make important progress advancing our 5x30 growth strategy to accelerate topline growth and fuel our ...
PARSIPPANY, N.J.PARSIPPANY, N.J. — PARSIPPANY, N.J. (AP) _ Pacira Pharmaceuticals Inc. (PCRX) on Thursday reported a loss of $2.8 million in its first quarter. The Parsippany, New Jersey-based company ...
PARSIPPANY, N.J.PARSIPPANY, N.J. — PARSIPPANY, N.J. (AP) _ Pacira Pharmaceuticals Inc. (PCRX) on Thursday reported second-quarter net income of $2.7 million. On a per-share basis, the Parsippany, New ...
SAN DIEGO, CA / ACCESS Newswire / January 22, 2025 / Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Pacira ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results